Shares of Orthofix Medical OFIX remained unaffected at $36.16 after the company reported Q1 results.
Quarterly Results
Earnings per share fell 66.67% over the past year to $0.09, which beat the estimate of $0.06.
Revenue of $104,823,000 lower by 3.93% year over year, which missed the estimate of $105,860,000.
Looking Ahead
Orthofix Medical hasn't issued any earnings guidance for the time being.
Orthofix Medical hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: May 08, 2020
Webcast URL: https://edge.media-server.com/mmc/p/qc9jp9an
Price Action
52-week high: $57.40
Company's 52-week low was at $22.11
Price action over last quarter: down 1.47%
Company Description
Orthofix Medical Inc is a medical device company that provides reconstructive and regenerative orthopedic and spine solutions to physicians. The company has four reportable segments include Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. It generates maximum revenue from Bone Growth Therapies segment. Geographically, it generates maximum revenue from a company the U.S and also has a presence in Italy, Germany, United Kingdom, Brazil, and other countries.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
